These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15857429)

  • 1. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.
    Majkowski J; Neto W; Wapenaar R; Van Oene J
    Epilepsia; 2005 May; 46(5):648-53. PubMed ID: 15857429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
    Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R
    Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
    Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
    Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD; Hulihan J; Karim MR; Wu SC; Jordan D; Karvois D; Kamin M
    Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of adverse events most commonly associated with topiramate for migraine prevention.
    Láinez MJ; Freitag FG; Pfeil J; Ascher S; Olson WH; Schwalen S
    Eur J Neurol; 2007 Aug; 14(8):900-6. PubMed ID: 17662012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
    Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study.
    Ramsay RE; Uthman B; Pryor FM; Rowan AJ; Bainbridge J; Spitz M; Sirven JI; Frederick TE
    Epilepsia; 2008 Jul; 49(7):1180-5. PubMed ID: 18494791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose topiramate in adults with treatment-resistant partial-onset seizures.
    Guberman A; Neto W; Gassmann-Mayer C;
    Acta Neurol Scand; 2002 Oct; 106(4):183-9. PubMed ID: 12225311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.
    Aldenkamp AP; Baker G; Mulder OG; Chadwick D; Cooper P; Doelman J; Duncan R; Gassmann-Mayer C; de Haan GJ; Hughson C; Hulsman J; Overweg J; Pledger G; Rentmeester TW; Riaz H; Wroe S
    Epilepsia; 2000 Sep; 41(9):1167-78. PubMed ID: 10999556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy.
    Yen DJ; Yu HY; Guo YC; Chen C; Yiu CH; Su MS
    Epilepsia; 2000 Sep; 41(9):1162-6. PubMed ID: 10999555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults.
    Reife R; Pledger G; Wu SC
    Epilepsia; 2000; 41(S1):66-71. PubMed ID: 10768304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy.
    Tassinari CA; Michelucci R; Chauvel P; Chodkiewicz J; Shorvon S; Henriksen O; Dam M; Reife R; Pledger G; Karim R
    Epilepsia; 1996 Aug; 37(8):763-8. PubMed ID: 8764816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
    Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
    Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
    Abou-Khalil B
    Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
    Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
    Elger C; Halász P; Maia J; Almeida L; Soares-da-Silva P;
    Epilepsia; 2009 Mar; 50(3):454-63. PubMed ID: 19243424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy.
    Ben-Menachem E; Sander JW; Stefan H; Schwalen S; Schäuble B
    Clin Ther; 2008 Jul; 30(7):1180-95. PubMed ID: 18691980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.